Genelink DNA Testing Lab  
  
www.Genelink.com  or     

www.Genelinkbio.com          GNLK (Stock Symbol)

         14 year old Public Company

                    5   US Patents
 US20040005566   US20020146698    US20070178518    US20030073612   US7211383 

Unprecedented Medical Advisory Board

      Dr. Bernard Kasten, former Chief Medical Officer Quest Diagnostics (8 years) is the author of many laboratory handbooks and is a Laboratory FDA Inspector
     
    Robert Ricciardi, Ph.D. has authored 55 publications and he has developed, patented, and has a patent pending for recombinant use in gene therapy.

  
   Harold H. Harrison M.D., Ph.D., F.C.A.P. Dr.  has served as Corporate Medical Director of Genetic

Services for Quest Diagnostics, and Medical Director for the biochemical, molecular, cytogenetic, and

laboratories of Genetrix, a national genetic services company 

  
   Donald J. Cannon, Ph.D has received his A.B. in Chemistry from Harvard College and a M.A. in Medical Sciences and a Ph.D in Biochemistry from Boston University has served as Laboratory Director in Forensic Toxicology, National Manager of Operations & Special Projects in Business Ventures at Quest Diagnostics.  He has over 130 publications and book chapters.

  GeneLink’s impeccably credentialed scientific group has scientists and researchers in  biotechnology, genomics, molecular biology, chemistry, medicine, clinical laboratory medicine and nutritional sciences. They have over 500 peer reviewed publications and abstracts, awards, dozens of patents & affiliations with public and private biosciences corporations and universities.